Exogenous Vasopressin-Induced Hyponatremia in Patients with Vasodilatory Shock: Two Case Reports and Literature Review

Journal of Intensive Care Medicine

Volumn 30, Issue 5, 2015, Pages 253-258

  Salazar, Miguel ^a   Hu, Bee Bee ^b   Vazquez, Joyce ^c   Wintz, Ruth L ^d,e,f,g   Varon, Joseph ^f,h,i  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b St Luke's Hospital   (United States)

^c UNIVERSIDAD ANÁHUAC   (Mexico)

^d Kidney Associates   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^g HOUSTON METHODIST HOSPITAL   (United States)

^h University General Hospital   (United States)

ⁱ UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

antidiuresis; hyponatremia; vasodilatory shock; vasopressin; vasopressors

Indexed keywords

ANTIBIOTIC AGENT; GLUCONATE ZINC; HARKOSERIDE; HYDROCORTISONE; LAMOTRIGINE; NORADRENALIN; PROPOFOL; PYRIDOXINE; SODIUM; SODIUM CHLORIDE; VASOPRESSIN; CORTICOSTEROID; VASOCONSTRICTOR AGENT; VASOPRESSIN DERIVATIVE; VASOPRESSIN RECEPTOR;

ACUTE RESPIRATORY FAILURE; ADULT; AIR CONDITIONING; ANTIBIOTIC THERAPY; ASPIRATION PNEUMONIA; CARDIOGENIC SHOCK; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; HYPONATREMIA; HYPOTENSION; MALE; MUSCLE ATROPHY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RESPIRATORY TRACT INTUBATION; RETT SYNDROME; REVIEW; SEIZURE; SEPTIC SHOCK; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL; URIC ACID BLOOD LEVEL; WILSON DISEASE; YOUNG ADULT; BLOOD; CHEMICALLY INDUCED; DIURESIS; DRUG EFFECTS; SHOCK, SEPTIC; WATER INTOXICATION;

ADRENAL CORTEX HORMONES; DIURESIS; FEMALE; HUMANS; HYPONATREMIA; MALE; RECEPTORS, VASOPRESSIN; SHOCK, SEPTIC; SODIUM; VASOCONSTRICTOR AGENTS; VASOPRESSINS; WATER INTOXICATION; YOUNG ADULT;

EID: 84930832084     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066613507410     Document Type: Review

References (49)

1. Errington ML, Rocha e Silva M. The secretion and clearance of vasopressin during the development of irreversible haemorrhagic shock. J Physiol. 1971 ; (217 suppl). 43P - 45P
2. Arnauld E, Czernichow P, Fumoux F, Vincent JD. The effects of hypotension and hypovolaemia on the liberation of vasopressin during haemorrhage in the unanaesthetized monkey (Macaca mulatta). Pflugers Arch. 1977 ; 371 (3). 193-200
3. Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997 ; 95 (5). 1122-1125
4. Sharshar T, Blanchard A, Paillard M, Raphael JC, Gajdos P, Annane D. Circulating vasopressin levels in septic shock. Crit Care Med. 2003 ; 31 (6). 1752-1758
5. Dünser MW, Mayr AJ, Ulmer H, et al. Arginine vasopressin in advanced vasodilatory shock. Circulation. 2003 ; 107 (18). 2313-2319
6. Obritsch MD, Jung R, Fish DN, MacLaren R. Effects of continuous vasopressin infusion in patients with septic shock. Ann Pharmacother. 2004 ; 38 (7-8). 1117-1122
7. Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology. 2002 ; 96 (3). 576-582
8. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013 ; 39 (2). 165-228
9. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely Ill patients. N Engl J Med. 2003 ; 348 (8). 727-734
10. Kristeller JL, Sterns RH. Transient diabetes insipidus after discontinuation of therapeutic vasopressin. Pharmacotherapy. 2004 ; 24 (4). 541-545
11. Sklar AH, Schrier RW. Central nervous system mediators of vasopressin release. Physiol Rev. 1983 ; 63 (4). 1243-1280
12. Goldsmith SR. Baroreceptor-mediated suppression of osmotically stimulated vasopressin in normal humans. J Appl Physiol. 1988 ; 65 (3). 1226-1230
13. Sharshar T, Carlier R, Blanchard A, et al. Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med. 2002 ; 30 (3). 497-500
14. Holmes CL, Patel BM, Russell JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest. 2001 ; 120 (3). 989-1002
15. Maybauer MO, Maybauer DM, Enkhbaatar P, Traber DL. Physiology of the vasopressin receptors. Best Pract Res Clin Anaesthesiol. 2008 ; 22 (2). 253-263
16. Holmes C, Landry D, Granton J. Science review: vasopressin and the cardiovascular system part 1 - receptor physiology. Crit Care. 2003 ; 7 (6). 427-434
17. Holt NF, Haspel KL. Vasopressin: a review of therapeutic applications. J Cardiothorac Vasc Anesth. 2010 ; 24 (2). 330-347
18. Obritsch MD, Bestul DJ, Jung R, Fish DN, MacLaren R. The role of vasopressin in vasodilatory septic shock. Pharmacotherapy. 2004 ; 24 (8). 1050-1063
19. Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008 ; 358 (9). 877-887
20. Choong K, Bohn D, Fraser DD, et al. Vasopressin in pediatric vasodilatory shock. Am J Respir Crit Care Med. 2009 ; 180 (7). 632-639
21. Baldasso E, Garcia P, Piva J, Branco R, Tasker R. Pilot safety study of low-dose vasopressin in non-septic critically ill children. Intensive Care Med. 2009 ; 35 (2). 355-359
22. Kravetz D, Bosch J, Teres J, Bruix J, Rimola A, Rodes J. Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal hemorrhage. Hepatology. 1984 ; 4 (3). 442-446
23. Melo JA, Lee M, Munoz J, Levine SM. Severe hyponatremia and bradycardia associated with intravenous vasopressin therapy for variceal hemorrhage. J Clin Gastroenterol. 1995 ; 20 (3). 266-268
24. Wilson MF, Brackett DJ, Tompkins P, Benjamin B, Archer LT, Hinshaw LB. Elevated plasma vasopressin concentrations during endotoxin and E. coli shock. Adv Shock Res. 1981 ; 6: 15-26
25. Wilson MF, Brackett DJ, Hinshaw LB, Tompkins P, Archer LT, Benjamin BA. Vasopressin release during sepsis and septic shock in baboons and dogs. Surg Gynecol Obstet. 1981 ; 153 (6). 869-872
26. Brackett DJ, Schaefer CF, Tompkins P, Fagraeus L, Peters LJ, Wilson MF. Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia. Circ Shock. 1985 ; 17 (4). 273-284
27. Grinevich V, Knepper MA, Verbalis J, Reyes I, Aguilera G. Acute endotoxemia in rats induces down-regulation of V2 vasopressin receptors and aquaporin-2 content in the kidney medulla. Kidney Int. 2004 ; 65 (1). 54-62
28. Chagnon F, Vaidya VS, Plante GE, et al. Modulation of aquaporin-2/vasopressin2 receptor kidney expression and tubular injury after endotoxin (lipopolysaccharide) challenge. Crit Care Med. 2008 ; 36 (11). 3054-3061
29. Jonassen TE, Graebe M, Promeneur D, Nielsen S, Christensen S, Olsen NV. Lipopolysaccharide-induced acute renal failure in conscious rats: effects of specific phosphodiesterase type 3 and 4 inhibition. J Pharmacol Exp Ther. 2002 ; 303 (1). 364-374
30. Versteilen AM, Heemskerk AE, Groeneveld AB, van Wijhe M, van Lambalgen AA, Tangelder GJ. Mechanisms of the urinary concentration defect and effect of desmopressin during endotoxemia in rats. Shock. 2008 ; 29 (2). 217-222
31. Ertmer C, Rehberg S, Morelli A, Westphal M. Current place of vasopressin analogues in the treatment of septic shock. Curr Infect Dis Rep. 2008 ; 10 (5). 362-367
32. Erkut ZA, Pool C, Swaab DF. Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons. J Clin Endocrinol Metab. 1998 ; 83 (6). 2066-2073
33. Raff H. Interactions between neurohypophysial hormones and the ACTH-adrenocortical axis. Ann N Y Acad Sci. 1993 ; 689: 411-425
34. Lauand F, Ruginsk SG, Rodrigues HL, et al. Glucocorticoid modulation of atrial natriuretic peptide, oxytocin, vasopressin and Fos expression in response to osmotic, angiotensinergic and cholinergic stimulation. Neuroscience. 2007 ; 147 (1). 247-257
35. Ruginsk SG, Oliveira FR, Margatho LO, Vivas L, Elias LL, Antunes-Rodrigues J. Glucocorticoid modulation of neuronal activity and hormone secretion induced by blood volume expansion. Exp Neurol. 2007 ; 206 (2). 192-200
36. Bahr V, Franzen N, Oelkers W, Pfeiffer AF, Diederich S. Effect of exogenous glucocorticoid on osmotically stimulated antidiuretic hormone secretion and on water reabsorption in man. Eur J Endocrinol. 2006 ; 155 (6). 845-848
37. Guillon G, Trueba M, Joubert D, et al. Vasopressin stimulates steroid secretion in human adrenal glands: comparison with angiotensin-II effect. Endocrinology. 1995 ; 136 (3). 1285-1295
38. Ahmed AB, George BC, Gonzalez-Auvert C, Dingman JF. Increased plasma arginine vasopressin in clinical adrenocortical insufficeincy and its inhibition by glucosteroids. J Clin Invest. 1967 ; 46 (1). 111-123
39. Saito T, Ishikawa SE, Ando F, et al. Exaggerated urinary excretion of aquaporin-2 in the pathological state of impaired water excretion dependent upon arginine vasopressin. J Clin Endocrinol Metab. 1998 ; 83 (11). 4034-4040
40. Russell JA, Walley KR, Gordon AC, et al. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med. 2009 ; 37 (3). 811-818
41. Muto S, Tabei K, Asano Y, Imai M. Dopaminergic inhibition of the action of vasopressin on the cortical collecting tubule. Eur J Pharmacol. 1985 ; 114 (3). 393-397
42. Sun D, Schafer JA. Dopamine inhibits AVP-dependent Na+ transport and water permeability in rat CCD via a D4-like receptor. Am J Physiol. 1996 ; 271 (2 pt 2). F391 - F400
43. Li L, Schafer JA. Dopamine inhibits vasopressin-dependent cAMP production in the rat cortical collecting duct. Am J Physiol. 1998 ; 275 (1 pt 2). F62 - F67
44. Edwards RM, Gellai M. Inhibition of vasopressin-stimulated cyclic AMP accumulation by alpha-2 adrenoceptor agonists in isolated papillary collecting ducts. J Pharmacol Exp Ther. 1988 ; 244 (2). 526-530
45. Edwards RM, Brooks DP. Dopamine inhibits vasopressin action in the rat inner medullary collecting duct via alpha(2)-adrenoceptors. J Pharmacol Exp Ther. 2001 ; 298 (3). 1001-1006
46. Nejsum LN, Zelenina M, Aperia A, Frokiaer J, Nielsen S. Bidirectional regulation of AQP2 trafficking and recycling: involvement of AQP2-S256 phosphorylation. Am J Physiol Renal Physiol. 2005 ; 288 (5). 29
47. Wagner RL, White PF, Kan PB, Rosenthal MH, Feldman D. Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med. 1984 ; 310 (22). 1415-1421
48. Cherfan AJ, Arabi YM, Al-Dorzi HM, Kenny LP. Advantages and disadvantages of etomidate use for intubation of patients with sepsis. Pharmacotherapy. 2012 ; 32 (5). 475-482
49. Liamis G, Milionis H, Elisaf M. A review of drug-induced hyponatremia. Am J Kidney Dis. 2008 ; 52 (1). 144-153